Tuberculosis Diagnostics
APAC · 1 shared keyword
APAC Left Atrial Appendage Closure Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
APAC · 2024–2034 · estimates
Market Dashboard
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Estimate 2024
$355.4 Mn
Estimated value
Estimate 2025
$415.9 Mn
19.3% of the global market
Projected 2034
$1.71 Bn 310.8%
Adds $1.29 Bn over 9 forecast years
CAGR 2025–2034
17.0%
Faster than 89% of 173 Medical Devices markets here
Key players
5
- APAC is 19.32% of the global market.
- Among regions, the largest is North America at $1.08 Bn.
- Fastest growing: Africa at 17.9% a year.
- APAC ranks 2nd of 6 by size among regions.
Market size projection
APACSource: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$1.29 Bn total, 2026–2034
Year-by-year market size, 2024–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $355.4 Mn | — | — |
| 2025 (base) | $415.9 Mn | +$60.4 Mn | — |
| 2026 (forecast) | $486.6 Mn | +$70.7 Mn | +17% |
| 2027 (forecast) | $569.3 Mn | +$82.7 Mn | +36.9% |
| 2028 (forecast) | $666.1 Mn | +$96.8 Mn | +60.2% |
| 2029 (forecast) | $779.3 Mn | +$113.2 Mn | +87.4% |
| 2030 (forecast) | $911.8 Mn | +$132.5 Mn | +119.2% |
| 2031 (forecast) | $1.07 Bn | +$155.0 Mn | +156.5% |
| 2032 (forecast) | $1.25 Bn | +$181.4 Mn | +200.1% |
| 2033 (forecast) | $1.46 Bn | +$212.2 Mn | +251.1% |
| 2034 (forecast) | $1.71 Bn | +$248.3 Mn | +310.8% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Same market worldwide
By geography
- Global $2.15 Bn
- North America $1.08 Bn
-
US
$963.1 Mn
- Europe $414.1 Mn
- APAC (this report) $415.9 Mn
-
Canada
$185.9 Mn
-
China
$158.8 Mn
-
Japan
$132.5 Mn
- Latin America $90.7 Mn
- Middle East $80.2 Mn
-
Germany
$72.1 Mn
-
UK
$61.4 Mn
-
Brazil
$56.0 Mn
-
Italy
$52.9 Mn
-
France
$50.3 Mn
-
India
$46.4 Mn
-
Saudi Arabia
$40.2 Mn
-
Spain
$37.7 Mn
-
Ecuador
$37.2 Mn
-
Mexico
$33.9 Mn
- Africa $34.5 Mn
-
New Zealand
$24.1 Mn
-
Australia
$24.8 Mn
-
Russia
$18.5 Mn
-
South Africa
$15.9 Mn
-
UAE
$9.7 Mn
-
Egypt
$6.7 Mn
-
Philippines
$4.9 Mn
-
Hong Kong
$3.8 Mn
-
Malaysia
$3.6 Mn
-
Singapore
$3.0 Mn
-
Thailand
$2.6 Mn
-
Kenya
$1.6 Mn
The APAC Left Atrial Appendage Closure Market Analysis Executive Summary
Left atrial appendage closure devices seal off a small pouch in the heart to lower stroke risk in people with atrial fibrillation.
Key segments of the left Atrial Appendage Closure market include product (Endocardial Devices and Epicardial Devices) and setting (Hospitals and Cardiac Centers).
APAC Left Atrial Appendage Closure Market Dynamics
Market Growth Drivers
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the left Atrial Appendage Closure market.
Opportunity
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the left Atrial Appendage Closure market room to grow.
Market Restraints
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the left Atrial Appendage Closure market.
Competitive Landscape for Left Atrial Appendage Closure Market in APAC
The left Atrial Appendage Closure market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Key Players
Healthcare Policies and Regulatory Landscape for Left Atrial Appendage Closure Market in APAC
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how left Atrial Appendage Closure products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Left Atrial Appendage Closure right now, from free public sources.
Latest research 1,353 papers since 2021 (worldwide)
- ASAP-TOO Stopped Too Soon: Right Question, Enormous Effort, and an Incomplete Answer. Journal of the American College of Cardiology, 2026
- Left Atrial Appendage Closure in Patients Considered Unsuitable for Oral Anticoagulation: Randomized Outcomes Through 5 Years in ASAP-TOO. Journal of the American College of Cardiology, 2026
- Individual Participant Data Meta-Analyses of Left Atrial Appendage Closure Trials: The Needed Next Step to Inform Clinical Decision-Making. Journal of the American College of Cardiology, 2026
- Percutaneous Left Atrial Appendage Closure vs Anticoagulation: More Shared Decision-Making or More Randomized Data? Journal of the American College of Cardiology, 2026
- Left Atrial Appendage Closure in Atrial Fibrillation Patients With High Risk of Stroke and Bleeding: An Individual Participant Data Meta-Analysis of Randomized Trials. Journal of the American College of Cardiology, 2026
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Left Atrial Appendage Closure in context
Questions, answered with public data
- How much research is published on Left Atrial Appendage Closure?
- PubMed lists 1,353 papers added since January 2021 that match this market, worldwide.[1]
[1] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Free data on this topic
From our blog
Omega-3: Heart, Brain and the Evidence DebateOmega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Angiography: Seeing Inside the Blood VesselsCardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
Rehabilitation Equipment: Recovery Beyond the Hospital2.4 billion people live with a condition that could benefit from rehabilitation. The need rose 63% since 1990.